FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition for HIV infection treatment includes lopinavir, ritonavir in an effective amount and a polymer. At that, the pharmaceutical composition is prepared by extrusion. The composition comprises a matrix polymer consisting of PEG 6000/vinylcaprolactam/vinyl acetate of 5 to 25% by weight of the pharmaceutical composition in combination with copovidone of 45 to 65% by weight of the pharmaceutical composition. The composition is extruded at a temperature of 105 to 145°C.
EFFECT: invention allows to expand the arsenal of drugs with enhanced pharmacokinetic properties.
9 cl, 3 dwg, 11 ex
Authors
Dates
2017-05-18—Published
2016-09-21—Filed